Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Oct 10, 2022 4:47pm
212 Views
Post# 35016096

RE:RE:RE:Three trials simultaneously...

RE:RE:RE:Three trials simultaneously...

Infinity still doesn't get it!  Gees!  This guy has no understanding of where TLT is now!

At one point in time, on its way to the next crucial milestone as it matures toward commercialization, a company doesn't just need money but rather money with connections that will open additional doors.  We have many examples of that.

We need key people to prepare for the next launch, facilitate things, etc ...

And such type of accredited investors offer those types of connections.  Not retail investors.

So whether it's Li Ka Shing/Frost type of deep pocket investors with connections, wealthy urologists of US private urology clinics that are already on the list of our clinical study sites, etc ..., TLT is probably priorizing investors that can bring it to the next step, so we can all benefit.  Not just retail investor that only have money but no connexion.

Time is now to connect to expertise, contacts.

 

<< Previous
Bullboard Posts
Next >>